Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes

Altres autors/es

[Gil-Moreno A, Carbonell-Socias M, Salicrú S, Bradbury M, Puig OP, Sánchez-Iglesias JL, Cabrera-Díaz S, de-la-Torre J, Gómez-Hidalgo NR, Pérez-Benavente A, Díaz-Feijoo B] Unitat de Ginecologia Oncològica, Servei d’Obstetrícia i Ginecologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [García Á] Servei de Patologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Vergés R] Servei de Radioteràpia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain.

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2020-02-14T12:41:57Z

2020-02-14T12:41:57Z

2019-07-16



Resum

Cervical cancer; Surgical treatment; Morbidity


Càncer cervical; Tractament quirúrgic; Morbilidad


Càncer cervical; Tractament quirúrgic; Morbiditat


OBJECTIVES: There are controversies regarding the long-term oncological safety of preservation of pelvic innervation during radical hysterectomy (RH). This study aimed to analyze the feasibility and safety of nerve-sparing radical hysterectomy (NSRH) for cervical cancer compared with non-NSRH following 17 years of experience in a tertiary cancer referral center. MATERIALS AND METHODS: Between May 1999 and June 2016, all patients who underwent RH for cervical cancer were followed-up prospectively. Comparison analyses regarding surgical outcomes, complications, overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS) were performed between patients treated with NSRH and non-NSRH. RESULTS: A total of 188 patients were included (113 non-NSRH and 75 NSRH). The median follow-up was 112 months. Estimated blood loss and hospital stay were all significantly lower in the NSRH group. Overall intraoperative complication rate (p = 0.02) and need for transfusion (p = 0.016) were lower in the NSRH group. There were no differences in the median operation time, OS, DFS, CSS, or recurrence rates between the NSRH and non-NSRH group. CONCLUSIONS: Our study provides a wide perspective on the developments of nerve-sparing procedures for the management of women with early-stage cervical cancer. Our results suggest that NSRH is a feasible and safe procedure, with reduced morbidity outcomes.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Impact Journals

Documents relacionats

Oncotarget;10(44)

http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=27078&path[]=86082

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)